A systematic review of the effectiveness of adalimumab
A systematic review of the effectiveness of adalimumab
A systematic review of the effectiveness of adalimumab
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
TABLE 147 Variation 14: TNF inhibitors third (early RA values) (100,000 patients) (cont’d)<br />
© Queen’s Printer and Controller <strong>of</strong> HMSO 2006. All rights reserved.<br />
Health Technology Assessment 2006; Vol. 10: No. 42<br />
Et+M – Ad+M 12,458 143 0.4914 0.0162<br />
Ad+M – In+M 238 127 0.0296 0.0154<br />
Et+M – In+M 12,695 141 0.5209 0.0161<br />
Comparison ICER (£ per QALY) Quasi-CI<br />
Adal – Base 35,300 34,200 to 36,500<br />
Etan – Base 30,800 30,200 to 31,500<br />
Ad+M – Base 30,700 29,800 to 31,500<br />
Et+M – Base 29,000 28,400 to 29,600<br />
In+M – Base 31,300 30,400 to 32,200<br />
Ad+M – Adal Adal+MTX more effective than Adal alone; diff. cost not significant<br />
Et+M – Etan 3,340 234 to 6,450<br />
Etan – Adal 23,000 21,500 to 24,600<br />
Et+M – Ad+M 25,400 23,700 to 27,300<br />
Ad+M – In+M Comparison is inconclusive<br />
Et+M – In+M 24,400 22,900 to 26,100<br />
TABLE 148 Variation 14: TNF inhibitors third (late RA values) (40,000 patients)<br />
Option Cost (£) QSE QALYs QSE<br />
Adal 48,510 154 5.6096 0.0234<br />
Etan 60,764 187 6.3362 0.0247<br />
Adal+MTX 48,682 154 5.8713 0.0232<br />
Etan+MTX 61,084 187 6.2842 0.0248<br />
Infl+MTX 48,029 148 5.6453 0.0235<br />
Base 16,478 36 5.3700 0.0217<br />
Comparison Diff. cost (£) QSE Diff. QALY QSE<br />
Adal – Base 32,032 150 0.2396 0.0223<br />
Etan – Base 44,286 181 0.9662 0.0237<br />
Ad+M – Base 32,204 150 0.5013 0.0225<br />
Et+M – Base 44,606 181 0.9141 0.0239<br />
In+M – Base 31,551 144 0.2753 0.0224<br />
Ad+M – Adal 172 202 0.2617 0.0227<br />
Etan – Et+M 319 240 –0.0521 0.0252<br />
Etan – Adal 12,255 224 0.7266 0.0239<br />
Et+M – Ad+M 12,402 223 0.4128 0.0242<br />
Ad+M – In+M 653 198 0.2260 0.0228<br />
Et+M – In+M 13,054 220 0.6389 0.0241<br />
Comparison ICER (£ per QALY) Quasi-CI<br />
Adal – Base 134,000 113,000 to 164,000<br />
Etan – Base 45,800 43,700 to 48,200<br />
Ad+M – Base 64,200 58,900 to 70,600<br />
Et+M – Base 48,800 46,300 to 51,500<br />
In+M – Base 115,000 98,600 to 137,000<br />
Ad+M – Adal Adal+MTX more effective than Adal alone; diff. cost not significant<br />
Etan – Et+M Etan+MTX more effective than Etan alone; diff. cost not significant<br />
Etan – Adal 16,900 15,700 to 18,200<br />
Et+M – Ad+M 30,000 26,800 to 34,200<br />
Ad+M – In+M 2,890 1,040 to 4,740<br />
Et+M – In+M 20,400 18,900 to 22,300<br />
215